Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
In today''s interconnected digital landscape, organizations are increasingly adopting global hybrid networks that combine ...
Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...
MedPage Today on MSN
GLP-1 Drugs Make Promising Debut in TAVR, Carotid Artery Stenting
Outcomes improved among structural heart and carotid revascularization populations ...
The State Department’s Directorate of Defense Trade Controls announced a $36 million penalty against General Electric after accusing it of multiple violations of the International Traffic in Arms ...
Transcatheter arterialization of the deep veins improves quality of life for no-option CLTI patients
Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...
Novel bioresorbable scaffold demonstrates primary patency rate of 97% at 3 years, indicative of long-term efficacy -- Achieved 1% post-procedural residual stenosis rate -- lowest rate ever reported in ...
This valuable study addressed a key question in epilepsy research: whether the recordings of very fast oscillations in the brain (>250Hz, fast ripples) reflect underlying pathology or might be a ...
PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with stable angina.
InVera Medical, a medical device company focused on advancing minimally-invasive technologies for Chronic Venous Disease, ...
The Centre's new Online Gaming rules, effective May 1, promote a light-touch regulation for social games in India.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results